pmtct : Search Results


  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 89
    Arvs Equipments pmtct services
    Proportion of women with ≥4 ANC visits, facility birth, and use of <t>ARVs</t> for <t>PMTCT</t> by HIV and disclosure status (n = 390).
    Pmtct Services, supplied by Arvs Equipments, used in various techniques. Bioz Stars score: 89/100, based on 23 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/pmtct services/product/Arvs Equipments
    Average 89 stars, based on 23 article reviews
    Price from $9.99 to $1999.99
    pmtct services - by Bioz Stars, 2020-11
    89/100 stars
      Buy from Supplier

    93
    STATA Corporation pmtct act
    Proportion of women with ≥4 ANC visits, facility birth, and use of <t>ARVs</t> for <t>PMTCT</t> by HIV and disclosure status (n = 390).
    Pmtct Act, supplied by STATA Corporation, used in various techniques. Bioz Stars score: 93/100, based on 2 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/pmtct act/product/STATA Corporation
    Average 93 stars, based on 2 article reviews
    Price from $9.99 to $1999.99
    pmtct act - by Bioz Stars, 2020-11
    93/100 stars
      Buy from Supplier

    85
    Arvs Equipments pmtct antiretrovirals
    Proportion of women with ≥4 ANC visits, facility birth, and use of <t>ARVs</t> for <t>PMTCT</t> by HIV and disclosure status (n = 390).
    Pmtct Antiretrovirals, supplied by Arvs Equipments, used in various techniques. Bioz Stars score: 85/100, based on 4 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/pmtct antiretrovirals/product/Arvs Equipments
    Average 85 stars, based on 4 article reviews
    Price from $9.99 to $1999.99
    pmtct antiretrovirals - by Bioz Stars, 2020-11
    85/100 stars
      Buy from Supplier

    85
    Arvs Equipments pmtct supplies
    Proportion of women with ≥4 ANC visits, facility birth, and use of <t>ARVs</t> for <t>PMTCT</t> by HIV and disclosure status (n = 390).
    Pmtct Supplies, supplied by Arvs Equipments, used in various techniques. Bioz Stars score: 85/100, based on 5 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/pmtct supplies/product/Arvs Equipments
    Average 85 stars, based on 5 article reviews
    Price from $9.99 to $1999.99
    pmtct supplies - by Bioz Stars, 2020-11
    85/100 stars
      Buy from Supplier

    85
    Boehringer Ingelheim pmtct programs
    Proportion of women with ≥4 ANC visits, facility birth, and use of <t>ARVs</t> for <t>PMTCT</t> by HIV and disclosure status (n = 390).
    Pmtct Programs, supplied by Boehringer Ingelheim, used in various techniques. Bioz Stars score: 85/100, based on 2 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/pmtct programs/product/Boehringer Ingelheim
    Average 85 stars, based on 2 article reviews
    Price from $9.99 to $1999.99
    pmtct programs - by Bioz Stars, 2020-11
    85/100 stars
      Buy from Supplier

    Image Search Results


    Proportion of women with ≥4 ANC visits, facility birth, and use of ARVs for PMTCT by HIV and disclosure status (n = 390).

    Journal: Journal of Acquired Immune Deficiency Syndromes (1999)

    Article Title: HIV-Positive Status Disclosure and Use of Essential PMTCT and Maternal Health Services in Rural Kenya

    doi: 10.1097/QAI.0000000000000376

    Figure Lengend Snippet: Proportion of women with ≥4 ANC visits, facility birth, and use of ARVs for PMTCT by HIV and disclosure status (n = 390).

    Article Snippet: PMTCT services, including the use of antiretroviral drugs (ARVs) during and after pregnancy, can improve survival of HIV-infected childbearing women and bring the rate of newborn infection to as low as 1%–2%., A critical component of both PMTCT and maternal health services is antenatal care (ANC), which includes HIV testing and counseling, pregnancy screening and monitoring, and treatment of complications.

    Techniques:

    “Cascade” of PMTCT and postnatal HIV care. Opportunities to maximize the effectiveness of PMTCT interventions may be lost at each step in the pathway. ANC: antenatal care, ARVs: antiretroviral drugs, ART: antiretroviral therapy, sdNVP: single-dose nevirapine.

    Journal: PLoS ONE

    Article Title: WHO 2010 Guidelines for Prevention of Mother-to-Child HIV Transmission in Zimbabwe: Modeling Clinical Outcomes in Infants and Mothers

    doi: 10.1371/journal.pone.0020224

    Figure Lengend Snippet: “Cascade” of PMTCT and postnatal HIV care. Opportunities to maximize the effectiveness of PMTCT interventions may be lost at each step in the pathway. ANC: antenatal care, ARVs: antiretroviral drugs, ART: antiretroviral therapy, sdNVP: single-dose nevirapine.

    Article Snippet: Although linkage to postnatal care was the access-to-care parameter with the greatest individual influence on maternal life expectancy, improved uptake at each step in a “cascade” of PMTCT care (including access to ANC, HIV testing and result receipt, and availability and acceptance of ARVs ; ) confers substantial benefits for both infant and maternal health.

    Techniques:

    Key sensitivity analyses, identifying selected parameters producing substantial changes in model results. As detailed in the Methods section and Appendix ( Text S1 ), a substantial change in results was defined as: 1) a change in the relative order of the outcomes of the PMTCT regimens, or 2) a > 10% relative change in the difference between projected outcomes for each regimen. Panel 2a depicts parameters influencing 18-month mother-to-child HIV transmission risk, and Panel 2b depicts parameters influencing maternal life expectancy from delivery; these outcomes are shown on the vertical axes. Along the horizontal axes, each group of vertical bars represents a single scenario (numbered 1–6 in 2a and 1–5 in 2b), and each vertical bar represents a PMTCT regimen, as indicated.

    Journal: PLoS ONE

    Article Title: WHO 2010 Guidelines for Prevention of Mother-to-Child HIV Transmission in Zimbabwe: Modeling Clinical Outcomes in Infants and Mothers

    doi: 10.1371/journal.pone.0020224

    Figure Lengend Snippet: Key sensitivity analyses, identifying selected parameters producing substantial changes in model results. As detailed in the Methods section and Appendix ( Text S1 ), a substantial change in results was defined as: 1) a change in the relative order of the outcomes of the PMTCT regimens, or 2) a > 10% relative change in the difference between projected outcomes for each regimen. Panel 2a depicts parameters influencing 18-month mother-to-child HIV transmission risk, and Panel 2b depicts parameters influencing maternal life expectancy from delivery; these outcomes are shown on the vertical axes. Along the horizontal axes, each group of vertical bars represents a single scenario (numbered 1–6 in 2a and 1–5 in 2b), and each vertical bar represents a PMTCT regimen, as indicated.

    Article Snippet: Although linkage to postnatal care was the access-to-care parameter with the greatest individual influence on maternal life expectancy, improved uptake at each step in a “cascade” of PMTCT care (including access to ANC, HIV testing and result receipt, and availability and acceptance of ARVs ; ) confers substantial benefits for both infant and maternal health.

    Techniques: Transmission Assay

    Sensitivity analysis demonstrating the impact on maternal life expectancy of rates of linkage to postnatal HIV care. The vertical axis represents maternal life expectancy, in years from delivery. The horizontal axis depicts the probability of linkage to postnatal HIV care for women who receive the PMTCT regimens shown. This probability of linkage to care is varied from 79% (the base case value) to 85%. In the base case, maternal life expectancy following the sdNVP and Option B regimens is lower than if no an tenatal ARVs were received for PMTCT (triangles). This occurs as a result of modeled negative impacts of sdNVP-associated resistance (sdNVP regimen) and ART interruption (Option B regimen). When the probability of linkage to care following Option B is ≥81.8%, as indicated by the open arrow (2.8% more than if no antenatal ARVs are received), the negative impact of ART interruption is overcome. Similarly, when the probability of linkage to care following sdNVP is ≥82.8%, as indicated by the solid arrow (3.8% more than if no ARVs are received), the negative impact of sdNVP-associated resistance is overcome.

    Journal: PLoS ONE

    Article Title: WHO 2010 Guidelines for Prevention of Mother-to-Child HIV Transmission in Zimbabwe: Modeling Clinical Outcomes in Infants and Mothers

    doi: 10.1371/journal.pone.0020224

    Figure Lengend Snippet: Sensitivity analysis demonstrating the impact on maternal life expectancy of rates of linkage to postnatal HIV care. The vertical axis represents maternal life expectancy, in years from delivery. The horizontal axis depicts the probability of linkage to postnatal HIV care for women who receive the PMTCT regimens shown. This probability of linkage to care is varied from 79% (the base case value) to 85%. In the base case, maternal life expectancy following the sdNVP and Option B regimens is lower than if no an tenatal ARVs were received for PMTCT (triangles). This occurs as a result of modeled negative impacts of sdNVP-associated resistance (sdNVP regimen) and ART interruption (Option B regimen). When the probability of linkage to care following Option B is ≥81.8%, as indicated by the open arrow (2.8% more than if no antenatal ARVs are received), the negative impact of ART interruption is overcome. Similarly, when the probability of linkage to care following sdNVP is ≥82.8%, as indicated by the solid arrow (3.8% more than if no ARVs are received), the negative impact of sdNVP-associated resistance is overcome.

    Article Snippet: Although linkage to postnatal care was the access-to-care parameter with the greatest individual influence on maternal life expectancy, improved uptake at each step in a “cascade” of PMTCT care (including access to ANC, HIV testing and result receipt, and availability and acceptance of ARVs ; ) confers substantial benefits for both infant and maternal health.

    Techniques: